Aurobindo Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 22, 2022 for RPR Sons Advisors, P Suneela Rani (Jointly holding).
The above information is a part of company’s filings submitted to BSE.